Actualités

Buying recent winners, particularly chip stocks, has been a working investment strategy until lately. That could turn out to be a blessing in disguise for the S&P 500.

Stocks were mixed ahead of Monday's closing bell after all three major indexes opened the session in the green. The Dow was down 0.6% or 300 points and the S&P 500 wavered at the flatline. Both indexes erased gains from the morning.

Are investors punishing SpaceX for a flight delay -- or for a too-high stock price?

Army cites manufacturing quality defects while GAO flags broader production delays across U.S. hypersonic missile programs.

All of these underlying businesses have one obvious thing in common.

Scott Melker host of Yahoo Finance's 'The Daily Wolf,' analyzes the regulatory delays surrounding the GENIUS Act's missed stablecoin rulemaking deadline and the growing legislative confusion impacting issuers like Tether and Circle.

Apple Drops Before Earnings Even as Bank of America Backs the Tech Giant

Investing.com -- Wells Fargo downgraded HubSpot to Equal Weight from Overweight and slashed its price target to $225 from $300, arguing that the software company's broad artificial intelligence transition is creating near-term uncertainty despite strengthening its long-term competitive position.

Fulfillment costs are also holding steady.

With the AI trade showing signs of fatigue, Procter & Gamble could emerge as a potential safe haven for investors.

Mizuho cuts Circle to underperform, citing rising stablecoin competition and risks from Open USD.

Strategy's Bitcoin sale and stalled U.S. crypto legislation add pressure as investor demand weakens.

The S&P 500 is hovering around all-time highs, but some investors worry a sell-off could be imminent.

Boeing investors will have a lot of news to digest this week. They should focus on supply chain updates.

Oracle and Bloom Energy shares fell after New Mexico rejected, for a second time, a permit needed for a pipeline serving Oracle's Project Jupiter AI data center.

Michael Saylor-led Strategy (Nasdaq: MSTR), formerly MicroStrategy, repeated its playbook from last week as it again sold the company's common shares to boost its cash reserve while adding no Bitcoin (BTC) to its balance sheet. The company disclosed in its filing with the Securities and ...

U.S. regulators walked back its findings about contaminated lettuce, saying that the Taylor Farms sample initially reported as positive for cyclospora was actually a false positive.

IBM just suffered its worst single-week collapse since 1968, yet one prominent analyst refuses to budge from a price target that implies more than 60% upside. What he sees in the wreckage that the sellers are missing could reshape the entire enterprise AI trade.

Procter & Gamble (PG) investors are bracing for the company's fiscal Q4 organic sales to fall short

Arbutus Biopharma and Genevant Sciences have filed multiple patent infringement lawsuits against Pfizer and BioNTech over their mRNA-LNP COVID-19 vaccines. The new cases extend beyond the existing U.S. litigation into several international jurisdictions. The lawsuits seek monetary damages and potential injunctions on vaccine products, raising legal and operational risks for Pfizer. Pfizer, listed as NYSE:PFE, is facing an expanded legal challenge as Arbutus Biopharma and Genevant Sciences...

According to a CNBC report, Morgan Stanley analyst Joseph Moore said in a note on Monday the firm's preferred AI investments remain compute names.

ARM’s stock saw the largest price target cut, though UBS reiterated its 'Buy' rating and retained 'Neutral' ratings for both Qualcomm and KLA.

These ETFs Face the Biggest Netflix Risk After Earnings Selloff

Monster Beverage (NASDAQ:MNST) was downgraded to Hold from Buy by Deutsche Bank, with analysts arguing that the energy drink maker’s recent share price rally has left limited room for further gains despite the company’s continued operational strength. The brokerage also increased its price target to $98 but noted that the revised target represents only around 1% upside from current levels.

Strategy stock rose early Monday after the bitcoin juggernaut disclosed that it raised $263 million by selling common stock last week.

The United States has been quietly draining its emergency oil stockpile at a record pace, and one analyst says the moment it runs dry could trigger a price shock the market is not prepared for.

Time for IBM to explore a different future?

Investing.com -- Monster Beverage was downgraded to Hold from Buy by analysts at Deutsche Bank, who said the energy drink maker's recent share outperformance has left its valuation reflecting expectations that are difficult to exceed despite the company's strong operational momentum.

AMS and its local partner MaxMass have provided mining services at the open-pit Iduapriem mine since 2018.

CLB struggles with ongoing headwinds from lower completion activity, operational disruptions, inflationary costs, weaker margins and projected earnings decline in 2026.